Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease

计划入组 100 人 · 首次发布于 2024 年 1 月 31 日

Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease (K-ELUVIA Registry)

计划入组 100 人 · 首次发布于 2018 年 4 月 23 日

Clinical Outcomes of GENOSS PCB for Femoropopliteal Artery Disease

计划入组 200 人 · 首次发布于 2026 年 2 月 10 日

Coronary artery disease gene therapy (BioCardia)

Coronary artery disease gene therapy(BioCardia, Inc.)

Dipep

Artery Therapeutics, Inc.

United States

Rare Disease Research, LLC

CASTLEMAN DISEASE COLLABORATIVE NETWORK

United States

SIRONA Trial: Sirolimus-Coated Balloons Show Non-Inferiority to Paclitaxel for Femoropopliteal Artery Disease

SurVeil DCB Shows Comparable Efficacy to IN.PACT Admiral with 75% Lower Paclitaxel Dose in TRANSCEND Trial

SIRONA Trial Completes Enrollment, Evaluating Sirolimus DCB for Peripheral Artery Disease